PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.71%
Both yoy net incomes decline, with AVGO at -9.78%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-36.15%
Both reduce yoy D&A, with AVGO at -0.37%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-88.89%
Negative yoy deferred tax while AVGO stands at 17.96%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-24.31%
Negative yoy working capital usage while AVGO is 18.76%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
194.12%
Inventory growth well above AVGO's 26.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-36.60%
Negative yoy usage while AVGO is 68.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
1215.38%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-7.05%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-19.08%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1300.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
58.67%
Purchases well above AVGO's 45.71%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
50.15%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-100.00%
Both yoy lines negative, with AVGO at -176.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
259.57%
Investing outflow well above AVGO's 23.56%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-59.64%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-33.29%
Both yoy lines negative, with AVGO at -107.07%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.